(Q37967040)

26 August 2017

title

Hypertension in 2011: New insights--from risk factors to treatment implications (English)

1 reference

26 August 2017

main subject

arterial hypertension

0 references

author name string

George L Bakris

series ordinal

1

1 reference

26 August 2017

language of work or name

English

0 references

publication date

13 December 2011

1 reference

Nature Reviews Cardiology

26 August 2017

published in

1 reference

26 August 2017

volume

9

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

75-77

1 reference

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.202

Decreased slow wave sleep increases risk of developing hypertension in elderly men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.202

The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.202

Management of blood pressure for acute and recurrent stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.202

Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.202

Projected effect of dietary salt reductions on future cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.202

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.202

Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.202

Should reducing nocturnal blood pressure be a therapeutic target in CKD? The time is ripe for a clinical outcomes trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.202

Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22158080

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCARDIO.2011.202

1 reference

26 August 2017

1 reference